WCG launches AI-driven Activation Intelligence to speed clinical trial start-ups

WCG, a provider of clinical trial solutions, announced a new AI-powered program called Activation Intelligence aimed at accelerating the start-up phase of studies.

In early access, the tool reportedly saved more than 20 hours of manual review per study activation for its first customers, while keeping data transparent.

The solution extracts study information once, validates it against source documents and reuses it across activation workflows, and includes an AI assistant that can answer queries and flag potential delays.

WCG says the offering is part of its broader Study Intelligence Hub, which seeks to apply purpose-built AI throughout trial operations to improve consistency and reduce re-work.